CoChat

Treatment of Obesity in Patients With Diabetes

Open access
Bramante, Carolyn T., Lee, Clare J., Gudzune, Kimberly A. · 2017 · Diabetes Spectrum
Cited by 92

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Abstract

IN BRIEF More than 90% of patients with diabetes have overweight or obesity. Whereas weight gain and obesity worsen insulin resistance, weight loss slows the progression of diabetes complications. Given the elevated risk for diabetes complications in patients with obesity, clinicians must understand how to treat obesity in their patients with diabetes, including providing counseling and behavioral management, referral to weight loss programs, and medication management. This article summarizes guidelines for diagnosing and managing obesity in people with diabetes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/ds17-0030

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 32 references

Research works printed but not linked: 34

  1. Macumber, 2017, Maternal obesity is associated with congenital anomalies of the kidney and urinary tract in offspring, Pediatr Nephrol, 32, 635, 10.1007/s00467-016-3543-x · DOI
  2. Mitchell, 2016, Understanding the effect of obesity on fertility among reproductive-age women, Nurs Womens Health, 20, 368, 10.1016/j.nwh.2016.07.001 · DOI
  3. Simeone, 2016, Proportion of selected congenital heart defects attributable to recognized risk factors, Ann Epidemiol, 26, 838, 10.1016/j.annepidem.2016.10.003 · DOI
  4. Bleich, 2012, National survey of US primary care physicians' perspectives about causes of obesity and solutions to improve care, BMJ Open, 2, 10.1136/bmjopen-2012-001871 · DOI
  5. Bennett, 2014, Insights from the POWER practice-based weight loss trial: a focus group study on the PCP's role in weight management, J Gen Intern Med, 29, 50, 10.1007/s11606-013-2562-6 · DOI
  6. Bennett, 2015, Satisfaction with primary care provider involvement is associated with greater weight loss: results from the practice-based POWER trial, Patient Educ Couns, 98, 1099, 10.1016/j.pec.2015.05.006 · DOI · Paper page
  7. Moyer, 2012, Screening for and management of obesity in adults: U.S. Preventive Services Task Force recommendation statement, Ann Intern Med, 157, 373, 10.7326/0003-4819-157-5-201209040-00475 · DOI · Paper page
  8. Leblanc, 2011, Effectiveness of primary care-relevant treatments for obesity in adults: a systematic evidence review for the U.S. Preventive Services Task Force, Ann Intern Med, 155, 434, 10.7326/0003-4819-155-7-201110040-00006 · DOI · Paper page
  9. Look AHEAD Research Group, 2017, Effects of a long-term lifestyle modification programme on peripheral neuropathy in overweight or obese adults with type 2 diabetes: the Look AHEAD study, Diabetologia, 60, 980, 10.1007/s00125-017-4253-z · DOI · Paper page
  10. Huizinga, 2009, Physician respect for patients with obesity, J Gen Intern Med, 24, 1236, 10.1007/s11606-009-1104-8 · DOI · Paper page
  11. Puhl, 2007, Internalization of weight bias: implications for binge eating and emotional well-being, Obesity (Silver Spring), 15, 19, 10.1038/oby.2007.521 · DOI · Paper page
  12. Alexander, 2011, Do the five A's work when physicians counsel about weight loss?, Fam Med, 43, 179
  13. Gudzune, 2016, Dietary and behavioral approaches in the management of obesity, Gastroenterol Clin North Am, 45, 653, 10.1016/j.gtc.2016.07.004 · DOI
  14. American Diabetes Association, 2016, Standards of medical care in diabetes—2016: abridged for primary care providers, Clin Diabetes, 34, 3, 10.2337/diaclin.34.1.3 · DOI · Paper page
  15. Gibbs, 2014, Effect of improved fitness beyond weight loss on cardiovascular risk factors in individuals with type 2 diabetes in the Look AHEAD study, Eur J Prev Cardiol, 21, 608, 10.1177/2047487312462823 · DOI · Paper page
  16. Wing, 2013, Effect of intensive lifestyle intervention on sexual dysfunction in women with type 2 diabetes: results from an ancillary Look AHEAD study, Diabetes Care, 36, 2937, 10.2337/dc13-0315 · DOI · Paper page
  17. Bloom, 2016, Guideline-concordant weight-loss programs in an urban area are uncommon and difficult to identify through the Internet, Obesity (Silver Spring), 24, 583, 10.1002/oby.21403 · DOI · Paper page
  18. Foster, 2013, A randomized comparison of a commercially available portion-controlled weight-loss intervention with a diabetes self-management education program, Nutr Diabetes, 3, e63, 10.1038/nutd.2013.3 · DOI · Paper page
  19. Pinto, 2013, Combining behavioral weight loss treatment and a commercial program: a randomized clinical trial, Obesity (Silver Spring), 21, 673, 10.1002/oby.20044 · DOI · Paper page
  20. Foster, 2009, The effects of a commercially available weight loss program among obese patients with type 2 diabetes: a randomized study, Postgrad Med, 121, 113, 10.3810/pgm.2009.09.2046 · DOI · Paper page
  21. Rock, 2007, Randomized trial of a multifaceted commercial weight loss program, Obesity (Silver Spring), 15, 939, 10.1038/oby.2007.614 · DOI · Paper page
  22. Jolly, 2010, A randomised controlled trial to compare a range of commercial or primary care led weight reduction programmes with a minimal intervention control for weight loss in obesity: the Lighten Up trial, BMC Public Health, 10, 439, 10.1186/1471-2458-10-439 · DOI · Paper page
  23. Johnston, 2014, Comparison of weight loss among named diet programs in overweight and obese adults: a meta-analysis, JAMA, 312, 923, 10.1001/jama.2014.10397 · DOI · Paper page
  24. Wing, 1998, Lifestyle intervention in overweight individuals with a family history of diabetes, Diabetes Care, 21, 350, 10.2337/diacare.21.3.350 · DOI · Paper page
  25. Helander, 2014, Are breaks in daily self-weighing associated with weight gain?, PLoS One, 9, 10.1371/journal.pone.0113164 · DOI · Paper page
  26. Seifarth, 2013, Effectiveness of metformin on weight loss in non-diabetic individuals with obesity, Exp Clin Endocrinol Diabetes, 121, 27
  27. Pratley, 2009, Alogliptin Study Group. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin in patients with type 2 diabetes inadequately controlled by glyburide monotherapy, Diabetes Obes Metab, 11, 167, 10.1111/j.1463-1326.2008.01016.x · DOI · Paper page
  28. Raz, 2008, Efficacy and safety of sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes, Curr Med Res Opin, 24, 537, 10.1185/030079908X260925 · DOI · Paper page
  29. Rosenstock, 2014, Improved glucose control with weight loss, lower insulin doses, and no increased hypoglycemia with empagliflozin added to titrated multiple daily injections of insulin in obese inadequately controlled type 2 diabetes, Diabetes Care, 37, 1815, 10.2337/dc13-3055 · DOI · Paper page
  30. Goldstein, 1992, Beneficial health effects of modest weight loss, Int J Obes Relat Metab Disord, 16, 397
  31. Jacob, 2009, Orlistat 120 mg improves glycaemic control in type 2 diabetic patients with or without concurrent weight loss, Diabetes Obes Metab, 11, 361, 10.1111/j.1463-1326.2008.00970.x · DOI · Paper page
  32. Mahgerefteh, 2013, New drug therapies for the treatment of overweight and obese patients, Am Health Drug Benefits, 6, 423
  33. Garvey, 2012, Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study, Am J Clin Nutr, 95, 297, 10.3945/ajcn.111.024927 · DOI · Paper page
  34. Makowski, 2011, Naltrexone/bupropion: an investigational combination for weight loss and maintenance, Obes Facts, 4, 489, 10.1159/000335352 · DOI

Cited by

See all 92

Metadata

Authors
Bramante, C. T., Lee, C. J., & Gudzune, K. A.
Venue
Diabetes Spectrum
Published
2017-11-01
Volume
30
Issue
4
Pages
237-243
ISSN
  • 1040-9165 (ISSN-L)
  • 1944-7353
OpenAlex
W2770569791
Cited by
92
References
32
FWCI
2.29
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Treatment of Obesity in Patients With Diabetes. https://app.cochat.ai/papers/10.2337/ds17-0030
The paper
Bramante, C. T., Lee, C. J., & Gudzune, K. A. (2017). Treatment of Obesity in Patients With Diabetes. Diabetes Spectrum. https://doi.org/10.2337/ds17-0030

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.